Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

203
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
203
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

122
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
122
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

320
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
320
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

301
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
301
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

651
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
651
Infection01:20

Infection

8.7K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
8.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Community-based serological screening for Chagas disease in London: a cross-sectional, observational pilot study.

BMJ public health·2025
Same author

Genital schistosomiasis in non-endemic settings: a clinical perspective.

Parasitology·2025
Same author

Recent Antiretroviral Therapy Initiation Is Associated With Increased Mortality Risk in HIV-associated Cryptococcal Meningitis: An Analysis of Clinical Trial Data From Africa.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

Female Genital Schistosomiasis (FGS) in a Nonendemic Setting: Retrospective Case-Notes Review of <i>Schistosoma haematobium</i>-Positive FGS Cases at the Hospital for Tropical Diseases, London, With a Pragmatic Clinical Pathway for Nonendemic Settings.

Open forum infectious diseases·2025
Same author

Personalised risk-prediction tools for cryptococcal meningitis mortality to guide treatment stratification in sub-Saharan Africa: a prognostic modelling study based on pooled analysis of two randomised controlled trials.

The Lancet. Global health·2025
Same author

Tick-borne encephalitis: from tick surveillance to the first confirmed human cases, the United Kingdom, 2015 to 2023.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2025

Related Experiment Video

Updated: Sep 14, 2025

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
06:55

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.

Published on: November 7, 2018

9.0K

Travellers' diarrhoea - solidifying our knowledgebase.

Thomas H A Samuels1,2, Clare E Warrell1,3

  • 1Hospital for Tropical Diseases, University College London Hospitals NHS Foundation Trust.

Current Opinion in Infectious Diseases
|July 23, 2025
PubMed
Summary
This summary is machine-generated.

Travellers' diarrhoea is common, with mild cases frequent. Advances in diagnostics and microbiome research offer new insights, but consensus on severity and rising antimicrobial resistance remain challenges.

Keywords:
antimicrobial resistancemicrobiometravel medicinetraveller's diarrhoea

More Related Videos

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases &#8212; Linking Intestinal Microbiome Insights to COPD Treatment
03:25

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

1.1K
Culture Methods to Determine the Limit of Detection and Survival in Transport Media of Campylobacter Jejuni in Human Fecal Specimens
08:23

Culture Methods to Determine the Limit of Detection and Survival in Transport Media of Campylobacter Jejuni in Human Fecal Specimens

Published on: March 10, 2020

11.7K

Related Experiment Videos

Last Updated: Sep 14, 2025

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
06:55

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.

Published on: November 7, 2018

9.0K
Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases &#8212; Linking Intestinal Microbiome Insights to COPD Treatment
03:25

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

1.1K
Culture Methods to Determine the Limit of Detection and Survival in Transport Media of Campylobacter Jejuni in Human Fecal Specimens
08:23

Culture Methods to Determine the Limit of Detection and Survival in Transport Media of Campylobacter Jejuni in Human Fecal Specimens

Published on: March 10, 2020

11.7K

Area of Science:

  • Infectious Diseases
  • Gastroenterology
  • Public Health

Background:

  • Travellers' diarrhoea (TD) is a prevalent illness among international travellers.
  • Effective prevention and management strategies for TD are not well-established.
  • Recent research highlights evolving aspects of TD, including epidemiology, diagnostics, and treatment.

Purpose of the Study:

  • To review recent advancements in the epidemiology, diagnostics, and management of travellers' diarrhoea.
  • To focus on novel severity definitions, molecular diagnostics, antimicrobial resistance, and postinfectious complications.
  • To identify key areas for future research and intervention in TD.

Main Methods:

  • Literature review of recent studies on travellers' diarrhoea.
  • Analysis of data on incidence, causative agents, and diagnostic methods.
  • Evaluation of current and emerging treatment and prevention strategies.

Main Results:

  • Travellers' diarrhoea incidence remains high, often mild, with viral cases increasingly identified via molecular diagnostics.
  • Microbiome research shows significant disruption post-TD and antibiotic use.
  • New severity definitions exist but lack consensus; nonabsorptive antibiotics and probiotics show promise, yet antimicrobial resistance is increasing.
  • Postinfectious irritable bowel syndrome (IBS) affects recovery for some patients.

Conclusions:

  • Consensus on TD severity definitions is crucial for developing new vaccines and therapeutics.
  • Priorities include surveillance of antimicrobial resistance, microbiome research, and development of probiotics and vaccines.
  • Improved understanding of TD pathophysiology and new interventions are needed to address post-TD IBS.